An organotypic model for investigating drug-radiation responses in the lung
Maryam Alkadhimi(University of Oxford), Anderson J. Ryan(University of Oxford)
Cited by 1
Related Papers
Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
|British Journal of Cancer|2009|65
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response
|Cancer Research|2021|49
Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice
|Clinical Cancer Research|2005|48
Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells
|Oncotarget|2014|46
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer
|Clinical and Translational Radiation Oncology|2020|34